Fox Chase’s Study Activation Unit Showcases Work in Clinical Research Innovation at National Meeting
Over the last few years, and without much fanfare, the Office of Clinical Research (OCR) has been diligently overhauling how Fox Chase Cancer Center initiates clinical trials and gets them running. They formed the Study Activation Unit (SAU), tasked with smashing through the walls that siloed different processes across the cancer center. Their success can be measured in time—from 2021 to 2023, the median time to new study activation dropped by a stunning 182 days, landing below their targeted goal of 90 days.